1700611-18-2 Usage
Uses
Used in Pharmaceutical Industry:
1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)is used as a potential active pharmaceutical ingredient for its possible biological activity due to the 3-amino-4-fluoro functionality. 1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)-'s structure may allow it to interact with specific biological targets, making it a candidate for drug development.
Used in Chemical Research:
1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)is used as a research compound for studying the effects of its unique molecular structure on chemical reactivity and potential interactions with biological systems. 1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)-'s properties, such as its lipophilicity and the spatial arrangement of functional groups, can provide insights into the design of new molecules with desired characteristics.
Used in Drug Delivery Systems:
1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)is used as a component in drug delivery systems to enhance the lipophilicity of other compounds, potentially improving their cell penetration and bioavailability. The 1,1-dimethylethyl ester group may facilitate the encapsulation or conjugation of therapeutic agents, allowing for more effective delivery to target tissues.
Check Digit Verification of cas no
The CAS Registry Mumber 1700611-18-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,0,0,6,1 and 1 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1700611-18:
(9*1)+(8*7)+(7*0)+(6*0)+(5*6)+(4*1)+(3*1)+(2*1)+(1*8)=112
112 % 10 = 2
So 1700611-18-2 is a valid CAS Registry Number.
1700611-18-2Relevant academic research and scientific papers
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
Page/Page column 77-78, (2009/12/23)
Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
